000 02693cam a2200301zu 4500
001 88963849
003 FRCYB88963849
005 20250429182316.0
006 m o d
007 cr un
008 250429s2022 fr | o|||||0|0|||eng d
020 _a9780128210932
035 _aFRCYB88963849
040 _aFR-PaCSA
_ben
_c
_erda
100 1 _aShah, Muhammad Raza
245 0 1 _aNanocarriers for Organ-Specific and Localized Drug Delivery
_c['Shah, Muhammad Raza', 'Malik, Muhammad Imran', 'Ullah, Shafi']
264 1 _bElsevier Science
_c2022
300 _a p.
336 _btxt
_2rdacontent
337 _bc
_2rdamdedia
338 _bc
_2rdacarrier
650 0 _a
700 0 _aShah, Muhammad Raza
700 0 _aMalik, Muhammad Imran
700 0 _aUllah, Shafi
856 4 0 _2Cyberlibris
_uhttps://international.scholarvox.com/netsen/book/88963849
_qtext/html
_a
520 _aOrgan-specific drug delivery is aimed at achieving increased concentration of therapeutic molecules at target sites with minimum side effects on other healthy tissues. Similarly, drug-specific delivery to some vital organs, such as the brain, lungs, heart and kidneys remains a challenging task for the formulation scientists. Oral delivery of most of the commercially available life-saving drugs has also been impeded by various physio-chemical and biological barriers. These advancements in nanotechnology have led to the development of various pharmaceutical nanocarriers.Nanocarriers for Organ-Specific and Localized Drug Delivery summarizes targeted drug delivery systems and approaches to the major organs of the body. The book shows how drugs can be specifically targeted to the pathological area within an organ in a viable way. Employing pharmaceutical nanocarriers for drug delivery targeted to specific organs of the body requires a comprehensive knowledge of the disease site's pathophysiology as well as physical, chemical and pharmaceutical techniques for modification or functionalization of the nanocarriers.Combining theoretical principles and practical applications of various nanocarriers for organ-specific drug delivery, this is an important reference source for all those seeking to increase their understanding of how pharmaceutical nanocarriers are being used to create more efficient drug delivery systems. - Outlines the underlying principles for the design of advanced pharmaceutical nanocarriers for organ specific drug delivery - Includes guidance on how to exploit the pathophysiology and microenvironment of the diseased sites for targeted drug delivery - Assesses the major challenges for creating pharmaceutical nanocarriers on a mass scale
999 _c1326821
_d1326821